< Back to companies
General Proximity

General Proximity

San Francisco, California, United States

General Proximity is a biotechnology startup pioneering next-generation proximity medicines that aim to redefine the future of medicine. By leveraging a mechanism-agnostic discovery engine, the company explores the intricate interactions between effector proteins to develop therapeutics targeting previously undruggable biological pathways. Their unbiased platform aims to enhance drug efficacy through controlling biological processes at a molecular level. Supported by major grants and collaborations with leading institutions, General Proximity has built a team with a remarkable track record of FDA-approved medicines and extensive patents and publications in the field of drug discovery and bioinformatics.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2019
Website
www.generalproximity.bio/

Categories

BiotechDrug DiscoveryTherapeuticsLife Sciences

Disease Areas

Technologies

BiotechnologyDrug DiscoveryTherapeuticsProtein Engineering
Only accessible to MedStartr community members. Join now

What do you think of General Proximity?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now